TLDR A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.
In 2019, a case study was conducted on a man in his 60s with myotonic dystrophy type 1 (DM1) who had 28 primary basal cell carcinomas (BCC) and four squamous cell carcinomas. Genetic testing ruled out known hereditary BCC-associated syndromes. The study suggested a link between DM1 and BCC, possibly due to the mutated DMPK gene in DM1 patients interfering with protein production, DNA repair, and cell death. This was the ninth reported case of DM1 associated with multiple, early-onset BCCs. The study emphasized the need for sun protection and skin cancer surveillance in DM1 patients, and the involvement of dermatologists in their care.
10 citations,
January 2016 in “Dermatology” People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.
23 citations,
January 2015 in “Journal of The American Academy of Dermatology” People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.
8 citations,
March 2015 in “Neuromuscular Disorders” People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.
23 citations,
January 2015 in “Journal of The American Academy of Dermatology” People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.
18 citations,
November 2016 in “Neuromuscular Disorders” Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.
16 citations,
July 2021 in “Histopathology” New markers and pathways have been found in skin tumors, helping better understand and diagnose them.
12 citations,
June 2016 in “Reviews in Endocrine and Metabolic Disorders” Some skin diseases and their treatments can negatively affect male fertility.